Botulinum toxin type A formulations are delicate biological proteins that require strict environmental controls to maintain molecular integrity and clinical potency. Korean botulinum toxins – including Innotox, Nabota, and Botulax – have gained widespread adoption in aesthetic medicine. Because these formulations vary between liquid ready-to-use solutions and lyophilized powders, healthcare professionals must understand and execute precise storage protocols. Proper handling prevents protein denaturation, guarantees predictable patient outcomes, and maintains compliance with medical storage regulations.
Biological products such as botulinum neurotoxin rely on secondary and tertiary protein structures to bind to presynaptic cholinergic nerve terminals. Any uncalibrated storage temperature or mechanical agitation disrupts these protein complexes, resulting in immediate loss of potency and variable treatment durations. — Dr. Erin Gilbert, Board-Certified Aesthetic Dermatologist.
For clinics looking to buy Korean Botox products, Beauty Dermal provides access to professionally sourced Korean botulinum toxin products with cold-chain handling and wholesale availability.
Core Storage Parameters for Korean Botulinum Toxins
Universal cold chain principles govern the management of all Korean botulinum toxin formulations. Unopened vials must remain in temperature-monitored medical refrigeration units between +2°C and +8°C. Exposure to ambient room temperatures, direct sunlight, or freezing conditions compromises the core neurotoxin complex.
- Maintain continuous refrigeration between +2°C and +8°C for both unopened liquid solutions and lyophilized powders.
- Protect vials from light by keeping them inside their original outer cardboard packaging until immediate point of use.
- Avoid freezing unopened liquid formulations like Innotox, as ice crystal formation damages active protein structures.
- Establish daily manual or automated logging of minimum and maximum refrigeration temperatures.
Brand-Specific Storage and Handling Guidelines
Korean manufacturers utilize different stabilization technologies and delivery formats. Clinical staff must differentiate between liquid preparations and lyophilized powders during storage and preparation.
- No reconstitution required; store opened vial at +2°C to +8°C per local IFU
| Brand Name | Formulation Type | Unopened Storage Temp | Unopened Shelf Life | Reconstituted Stability |
| Innotox | Liquid Solution (Ready-to-use) | +2°C to +8°C | 24 to 36 Months | |
| Nabota | Lyophilized Powder | +2°C to +8°C | 36 Months | Use within 24 hours (+2°C to +8°C) |
| Botulax | Lyophilized Powder | +2°C to +8°C | 24 to 36 Months | Use within 24 hours (+2°C to +8°C) |
Innotox Handling Protocols
Manufactured by Medytox Inc., Innotox is formulated as a pre-mixed liquid solution that eliminates reconstitution errors. Because it contains liquid phase proteins, it exhibits higher sensitivity to temperature spikes than lyophilized equivalents. Innotox must remain upright in its original packaging between +2°C and +8°C and should never be subjected to sub-zero temperatures.
Nabota Handling Protocols
Developed by Daewoong Pharmaceutical, Nabota is supplied as a purified lyophilized vacuum-dried powder. Unopened vials maintain stability for up to 36 months under continuous refrigeration at +2°C to +8°C. Once reconstituted with preservative-free 0.9% sodium chloride, Nabota must be administered within 24 hours and kept chilled between treatments.
Botulax Handling Protocols
Produced by Hugel, Botulax is a vacuum-dried lyophilized powder available in multiple unit sizes. It requires continuous refrigeration at +2°C to +8°C, isolated from direct light sources. Reconstitution requires slow, gentle introduction of sterile saline down the internal glass wall to prevent foam formation and protein shearing.
Lyophilized powders offer excellent long-term stability prior to mixing. However, once reconstituted with sterile saline, the absence of chemical preservatives creates a dual risk: rapid bacterial colonization and enzymatic neurotoxin degradation. The 24-hour post-reconstitution threshold must be strictly enforced. — Marcus Vance, Clinical Pharmacologist
Medical Refrigeration Best Practices
Standard domestic refrigerators are inadequate for medical storage because of internal temperature gradients, defrost cycles, and frequent door openings. Practices handling botulinum toxin products should utilize dedicated pharmacy-grade refrigeration units.
- Position toxins on center shelves where air circulation is stable, avoiding back cooling plates and door compartments.
- Install calibrated digital data loggers that record ambient temperature intervals every 15 minutes.
- Set visual and auditory alarms to trigger if internal temperatures drop below +2°C or exceed +8°C.
- Maintain dedicated refrigeration units exclusively for pharmaceuticals; store no food, beverages, or biological samples alongside medications.
Handling Reconstituted Solutions and Preventing Contamination
Reconstitution transforms stable vacuum-dried toxin into an active aqueous solution. Maintaining aseptic technique and strict time management prevents product waste and patient infection.
| Preparation Step | Standard Operating Procedure | Risk Mitigated |
| Diluent Selection | Preservative-free sterile 0.9% Sodium Chloride Injection | Precipitation & Potency Loss |
| Saline Addition | Slow laminar flow along internal vial wall; do not agitate | Protein Denaturation & Shearing |
| Vial Labeling | Record date, exact time, concentration, and clinician initials | Dosing Errors & Out-of-date Use |
| Storage Post-Mix | Re-refrigerate at +2°C to +8°C; do not freeze | Bacterial Growth & Potency Decay |
Prior to drawing solution into treatment syringes, clean the rubber stopper thoroughly with a 70% isopropyl alcohol wipe and allow it to dry completely. Inspect the solution visually under bright light; discard any vial displaying turbidity, particulate matter, or discoloration.
Inventory Control, FIFO, and Cold Chain Logistics
Cold chain integrity must extend from manufacturer dispatch through final patient administration. Clinic inventory processes should prevent stock expiration and track batch movement.
- Implement a First-In, First-Out (FIFO) stock management system, positioning products with the shortest remaining shelf life at the front of refrigeration shelves.
- Log incoming shipments immediately upon arrival, verifying intact security seals and checking temperature indicator cards included in shipping containers.
- Record batch numbers, lot details, arrival dates, and expiration dates in a centralized inventory management system.
- Perform monthly audits to clear near-expiration items and audit usage metrics against patient treatment records.
A robust cold chain relies on continuous verification. If a shipping box arrives with melted ice packs or an unmonitored transit log, clinicians should assume temperature compliance was compromised and reject the shipment to safeguard patient outcomes. — Sarah Jenkins, Medical Cold Chain Specialist
Clinic SOP Workflow: Storage to Administration
Establishing clear Standard Operating Procedures (SOPs) minimizes human error during daily clinical operations.
- Accept shipment and verify that temperature monitoring indicators during transport remained within safe limits.
- Transfer unopened vials into the primary medical refrigerator immediately.
- Verify treatment schedules each morning and remove only the required number of unopened vials.
- Perform reconstitution using sterile technique in a dedicated drug preparation area.
- Affix a complete preparation label to the reconstituted vial before placing it in a chilled tray for transport to the treatment room.
- Return unused portions of reconstituted vials to the refrigerator immediately following procedure completion.
- Discard any reconstituted product that exceeds the 24-hour limit in accordance with clinical waste protocols.
Disposal of Expired or Compromised Toxins
Unused, expired, or compromised botulinum toxin vials remain biologically active hazardous materials and require formal medical disposal protocols.
- Never dispose of empty, expired, or damaged toxin vials in regular municipal trash or liquid drainage systems.
- Place used syringes and empty vials into rigid, puncture-resistant biohazard sharps containers.
- Neutralize major spills or broken vials using a diluted hypochlorite solution (0.5% available chlorine) before cleaning with absorbent materials.
- Contract with licensed medical waste management services for high-temperature incineration of pharmaceutical waste.
- Document all discarded items in the clinic inventory waste log, including batch numbers, unit quantities, and reason for disposal.
FAQ
What is the correct storage temperature for unopened Korean Botox products?
Unopened Korean botulinum toxin products, including Innotox, Nabota, and Botulax, must be stored in a dedicated medical refrigerator at temperatures between +2°C and +8°C, protected from light.
How long can reconstituted Nabota or Botulax be stored in the refrigerator?
Reconstituted Nabota and Botulax solutions should be stored at +2°C to +8°C and administered within 24 hours of preparation to ensure maximum potency and reduce infection risk.
Can you freeze Innotox, Nabota, or Botulax to extend their shelf life?
No. Freezing liquid toxins like Innotox causes protein denaturation through ice crystal formation. Reconstituted powders should never be frozen after saline addition.
What should be done if a clinic loses power and refrigerator temperatures exceed +8°C?
If temperatures exceed +8°C, keep refrigerator doors closed and monitor internal temperature data loggers. Document the duration of the excursion and consult the manufacturer or medical compliance team before administering affected stock.
Why are domestic fridges unsuitable for storing botulinum toxin products?
Domestic refrigerators experience severe temperature variations, lack continuous logging and alarm systems, and do not maintain uniform cooling across all shelves, raising the risk of product degradation.
Source List
- Medytox Inc. Innotox Product Specifications and Storage Guidelines. https://www.medytox.com
- Daewoong Pharmaceutical. Nabota (Botulinum Toxin Type A) Prescribing Information and Handling Datasheet. https://www.mims.com
- New Zealand Medicines and Medical Devices Safety Authority (Medsafe). Nabota Data Sheet: Storage, Reconstitution, and Stability Parameters. https://www.medsafe.govt.nz
- Hugel Inc. Botulax Professional Product Manual and Cold Chain Storage SOP. https://www.hugel.co.kr
This article provides general educational information and is not medical advice.
Disclaimer – Dr. Diana Rangaves, PharmD
A licensed healthcare professional must evaluate whether testing or treatment is appropriate for an individual patient.
